NPPA issued a notification regarding the fixation of the retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg + Glimepiride IP 2mg

Jul 24, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 23, 2024, issued a notification regarding the fixation of the retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg + Glimepiride IP 2mg.

The following has been stated: -

•For Each film-coated tablet containing: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg + Glimepiride IP 2mg for M/s Synokem Pharmaceuticals Ltd (Manufacturer) & M/s Apex Laboratories Pvt Ltd (Marketer) the retail price is 11.60 (Rs.)

[Notification No. 19(4098) /2024/DP/NPPA/Div.III/8551/2024]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT